186 related articles for article (PubMed ID: 10852542)
21. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy.
Comi C; Gaviani P; Leone M; Ferretti M; Castelli L; Mesturini R; Ubezio G; Chiocchetti A; Osio M; Muscia F; Bogliun G; Corso G; Gavazzi A; Mariani C; Cantello R; Monaco F; Dianzani U
J Peripher Nerv Syst; 2006 Mar; 11(1):53-60. PubMed ID: 16519782
[TBL] [Abstract][Full Text] [Related]
22. Antibodies to L-periaxin in sera of patients with peripheral neuropathy produce experimental sensory nerve conduction deficits.
Lawlor MW; Richards MP; De Vries GH; Fisher MA; Stubbs EB
J Neurochem; 2002 Nov; 83(3):592-600. PubMed ID: 12390521
[TBL] [Abstract][Full Text] [Related]
23. Chronic inflammatory demyelinating polyneuropathy: a 6-year retrospective clinical study of a hospital-based population.
Rentzos M; Anyfanti C; Kaponi A; Pandis D; Ioannou M; Vassilopoulos D
J Clin Neurosci; 2007 Mar; 14(3):229-35. PubMed ID: 17258131
[TBL] [Abstract][Full Text] [Related]
24. Chronic dysimmune neuropathy. A subclassification based upon the clinical features of 102 patients.
Busby M; Donaghy M
J Neurol; 2003 Jun; 250(6):714-24. PubMed ID: 12796835
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA; Allen D; Makowska A; Gregson NA
J Peripher Nerv Syst; 2006 Mar; 11(1):30-46. PubMed ID: 16519780
[TBL] [Abstract][Full Text] [Related]
26. Chronic inflammatory demyelinating polyneuropathy.
Rizzuto N; Simonati A
Int J Tissue React; 1985; 7(6):521-6. PubMed ID: 4086221
[TBL] [Abstract][Full Text] [Related]
27. Dispersion of the distal compound muscle action potential in chronic inflammatory demyelinating polyneuropathy and carpal tunnel syndrome.
Cleland JC; Logigian EL; Thaisetthawatkul P; Herrmann DN
Muscle Nerve; 2003 Aug; 28(2):189-93. PubMed ID: 12872323
[TBL] [Abstract][Full Text] [Related]
28. Length-dependent weakness and electrophysiological signs of secondary axonal loss in chronic inflammatory demyelinating polyradiculoneuropathy.
Harbo T; Andersen H; Jakobsen J
Muscle Nerve; 2008 Aug; 38(2):1036-45. PubMed ID: 18642356
[TBL] [Abstract][Full Text] [Related]
29. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve.
Sumner AJ; Saida K; Saida T; Silberberg DH; Asbury AK
Ann Neurol; 1982 May; 11(5):469-77. PubMed ID: 6285800
[TBL] [Abstract][Full Text] [Related]
30. Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy.
Magda P; Latov N; Brannagan TH; Weimer LH; Chin RL; Sander HW
Arch Neurol; 2003 Dec; 60(12):1755-9. PubMed ID: 14676052
[TBL] [Abstract][Full Text] [Related]
31. Antibodies to gliomedin cause peripheral demyelinating neuropathy and the dismantling of the nodes of Ranvier.
Devaux JJ
Am J Pathol; 2012 Oct; 181(4):1402-13. PubMed ID: 22885108
[TBL] [Abstract][Full Text] [Related]
32. Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?
Oh SJ; Claussen GC; Kim DS
J Peripher Nerv Syst; 1997; 2(4):362-9. PubMed ID: 10975745
[TBL] [Abstract][Full Text] [Related]
33. Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.
Cocito D; Ciaramitaro P; Isoardo G; Barbero P; Migliaretti G; Pipieri A; Proto G; Quadri R; Bergamasco B; Durelli L
J Neurol; 2002 Jun; 249(6):719-22. PubMed ID: 12111305
[TBL] [Abstract][Full Text] [Related]
34. [Structural characteristics of sural nerve myelin from patients with chronic inflammatory demyelinating polyneuropathy: an X-ray diffraction study].
Vargas Leal V; Cotúa Salazar M; Borges Iturriza J; Vonasek Golcz E; Vargas R; Céspedes-Caravaca G; Mateu-Suay L
Rev Neurol; 2003 Apr 1-15; 36(7):614-9. PubMed ID: 12666039
[TBL] [Abstract][Full Text] [Related]
35. Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis.
Sharma KR; Saadia D; Facca AG; Bhatia R; Ayyar DR; Sheremata W
J Clin Neuromuscul Dis; 2008 Jun; 9(4):385-96. PubMed ID: 18525422
[TBL] [Abstract][Full Text] [Related]
36. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy.
Van den Bergh PY; Piéret F
Muscle Nerve; 2004 Apr; 29(4):565-74. PubMed ID: 15052622
[TBL] [Abstract][Full Text] [Related]
37. Onset and course of chronic inflammatory demyelinating polyneuropathy.
Mygland A; Monstad P; Vedeler C
Muscle Nerve; 2005 May; 31(5):589-93. PubMed ID: 15742374
[TBL] [Abstract][Full Text] [Related]
38. Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.
Berger AR; Bradley WG; Brannagan TH; Busis NA; Cros DP; Dalakas MC; Danon MJ; Donofrio P; Engel WK; England JD; Feldman EL; Freeman RL; Kinsella LJ; Lacomis D; Latov N; Menkes DL; Sander HW; Thomas FP; Triggs WJ; Windebank AJ; Wolfe GI;
J Peripher Nerv Syst; 2003 Dec; 8(4):282-4. PubMed ID: 14641652
[No Abstract] [Full Text] [Related]
39. [Importance of the nerve biopsy for the diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuritis: 8 cases].
Vallat JM; Tabaraud F; Magy L; Couratier P
Bull Acad Natl Med; 2003; 187(2):387-99; discussion 399-403. PubMed ID: 14556448
[TBL] [Abstract][Full Text] [Related]
40. Antibody- and macrophage-mediated segmental demyelination in chronic inflammatory demyelinating polyneuropathy: clinical, electrophysiological, immunological and pathological correlates.
Vallat JM; Mathis S; Vegezzi E; Richard L; Duchesne M; Gallouedec G; Corcia P; Magy L; Uncini A; Devaux J
Eur J Neurol; 2020 Apr; 27(4):692-701. PubMed ID: 31769579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
